Skip to content

Health-related Quality of Life in Colon Cancer

Health-related Quality of Life in Colon Cancer Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03910894
Enrollment
376
Registered
2019-04-10
Start date
2012-03-31
Completion date
2022-09-30
Last updated
2019-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Related Quality of Life

Brief summary

This study investigates health-related Quality of life in colon cancer patients in Västmanland, Sweden, at diagnosis, at 6 months, 1, 2 and 3 years after diagnosis, measured by the well-validated EORTC QLQ-C30 questionnaire.

Detailed description

See above.

Interventions

None listed

Sponsors

Region Västmanland
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

All patients diagnosed with colon cancer in Region Västmanland 2012-2016.

Exclusion criteria

Language problems, declined inclusion,

Design outcomes

Primary

MeasureTime frameDescription
Health-related Quality of Life2012-2016The EORTC QLQ-C30, a HRQoL questionnaire was used. It consists of 30 items comprising five functional scales (physical, role, emotional, cognitive, and social), three symptom scales (fatigue, nausea and vomiting, and pain). Six single items are also included (dyspnoea, insomnia, appetite loss, constipation, diarrhoea, and financial difficulties). The final two items in the questionnaire assess global health and overall QoL. Raw data were transformed to standardized scores ranging from 0 to 100 using the EORTC scoring manual. A high score on the functional scale represents a high level of functioning (i.e., higher is better), whereas a high score on the symptom scale represents a high level of symptoms (i.e., lower is better).

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026